Clinical and In Vitro Safety of <i>Heyndrickxia coagulans</i> AO 1167B: A Double-Blind, Placebo-Controlled Trial
(1) Background: <i>Heyndrickxia coagulans</i>, a lactic acid-producing bacterium, displays characteristics of both <i>Lactobacillus</i> and <i>Bacillus</i> genera. Clinical evidence suggests its potential health benefits. This study evaluated the safety of <i&g...
Saved in:
| Main Authors: | Gissel García, Josanne Soto, Antonio Díaz, Jesús Barreto, Carmen Soto, Ana Beatriz Pérez, Suselys Boffill, Ángela Gutiérrez, Raúl de Jesús Cano |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Microorganisms |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-2607/12/12/2584 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comprehensive genomic analysis and evaluation of in vivo and in vitro safety of Heyndrickxia coagulans BC99
by: Ying Wu, et al.
Published: (2024-11-01) -
Multifunctional probiotic and safety attributes Heyndrickxia coagulans isolated from stingless bee honey
by: Benyapa Prakit, et al.
Published: (2025-01-01) -
Effects of <i>Heyndrickxia coagulans</i> on Waterborne Copper Toxicity
by: Chung-Tsui Huang, et al.
Published: (2025-02-01) -
Heyndrickxia coagulans SANK70258 supplementation improves growth performance, gut health, and liver function in growing pigs
by: Masanori Aida, et al.
Published: (2025-05-01) -
Human in vivo assessment of the survival and germination of Heyndrickxia coagulans SNZ1969 spores delivered via gummy candies
by: Susanna Perotti, et al.
Published: (2024-01-01)